Acute kidney injury(AKI) is a rapid decline in glomerular function rate(GFR) and its diagnosis is currently based on functional biomarkers, serum creatinine, and blood urea nitrogen which are not very specific and sensitive. Among many potential noninvasive AKI biomarkers, KIM-1 is one of them. CABG, which employs cardiopulmonary bypass, is the most common cause of acute kidney injury. Aim of the study was to find the role of urinary KIM-1 as an early diagnostic marker of AKI in patients who have undergone CABG and objectives were assessed by measuring Urinary KIM-1, 6 hours post CABG to identify it as an early diagnostic marker of AKI. It’s a cross-sectional study carried out at Sri Ramachandra Medical College and Research Institute. It includes 80 patients aged between 30-60 years and undergoing CABG. Urinary KIM-1 was measured 6 hours and Serum creatinine was measured 48 hours post-CABG. Out of 80, 10 patients developed AKI, and 70 patients did not develop AKI. Urinary KIM-1 and serum creatinine measured in AKI and non-AKI patients were analysed using SPSS software 16.0. The mean ± SD of urinary KIM-1 in patients with AKI was 5.936±2.002, which was significantly higher (p<0.0001) than patients who did not develop AKI. Mean ± SD of serum creatinine in patients with AKI was significantly higher(P<0.0001) than patients who did not develop AKI. This study showed significantly higher concentrations of urinary KIM-1, 6 hours Post-CABG patients who developed AKI, making it an early biomarker for diagnosis of acute kidney injury in them.
Branislava M, Branislav R, Basta Jovanovic G. Sanja Radojevi skodric, Milica Prostran Kidney injury Molecule-1 and cardiovascular diseases: from basic science to clinical practice. BioMed Res Int. 2015;2015:854070.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. CC. 2007 Apr 1;11(2):R31.
Mactier RA, Tomson CR. Executive summary of the fifth edition of the Renal Association Clinical Practice Guidelines (2009-2012). Nephron Clin Pract. 2011 May 1;118;Suppl 1:c5-c11. doi: 10.1159/000328058, PMID 21555904.
Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004 Jul 1;114(1):5-14. doi: 10.1172/JCI22353, PMID 15232604.
Chawla LS, Amdur RL, Shaw AD, Faselis C, Palant CE, Kimmel PL. Association between AKI and long-term renal and cardiovascular outcomes in United States veterans. Clin J Am Soc Nephrol. 2014;9(3):448-56. doi: 10.2215/CJN.02440213, PMID 24311708.
Iqbal AW. Acute kidney injury after adult cardiac surgery with cardiopulmonary bypass: incidence and predictors. Pak J Med Health Sci. 2014;8(1).
Loef BG, Epema AH, Smilde TD, Henning RH, Ebels T, Navis G et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol. 2005 Jan 1;16(1):195-200. doi: 10.1681/ASN.2003100875, PMID 15563558.
Rydén L, Sartipy U, Evans M, Holzmann MJ. Acute kidney injuries after coronary artery bypass grafting and long-term risk of end-stage renal disease. Circulation. 2014 Dec 2;130(23):2005-11. doi: 10.1161/CIRCULATIONAHA.114.010622, PMID 25239439.
Ascione R, Lloyd CT, Underwood MJ, Gomes WJ, Angelini GD. On-pump versus of-pump coronary revascularization: evaluation of renal function. Ann Thorac Surg. 1999;68(2):493-8. doi: 10.1016/s0003-4975(99)00566-4, PMID 10475418.
Sanoff S, Okusa MD. Impact of acute kidney injury on chronic kidney disease and its progression. In: Hemodialysis. Vol. 171. Karger Publishers; 2011. doi: 10.1159/000327332, PMID 21625114.
Murray PT, Devarajan P, Levey AS, Eckardt KU, Bonventre JV, Lombardi R, et al. A framework and key research questions in AKI diagnosis and staging in different environments. Clin J Am Soc Nephrol. 2008 May 1;3(3):864-8. doi: 10.2215/CJN.04851107, PMID 18287251.
Waikar SS, Betensky RA, Bonventre JV. Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant. 2009;24(11):3263-5. doi: 10.1093/ndt/gfp428, PMID 19736243.
Chaturvedi S, Farmer T, Kapke GF. Assay validation for KIM-1: human urinary renal dysfunction biomarker. Int J Biol Sci. 2009;5(2):128-34. doi: 10.7150/ijbs.5.128, PMID 19173034.
Najafi M. Serum creatinine role in predicting outcome after cardiac surgery beyond acute kidney injury. World J Cardiol. 2014 Sep 26;6(9):1006-21. doi: 10.4330/wjc.v6.i9.1006, PMID 25276301.
Wagener G, Minhaz M, Mattis FA, Kim M, Emond JC, Lee HT. Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation. Nephrol Dial Transplant. 2011;26(5):1717-23. doi: 10.1093/ndt/gfq770, PMID 21257679.
Boventure.chap 29. Venkata sabbisetti and Joseph V. In: Biomarkers in acute and chronic kidney diseases. The kidney Brenner and Rector. 9th ed.
Cruz DN, Bagshaw SM, Maisel A, Lewington A, Thadhani R, Chakravarthi R, et al. Use of biomarkers to assess prognosis and guide management of patients with acute kidney injury. Contrib Nephrol. 2013;182:45-64. doi: 10.1159/000349965, PMID 23689655.
Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998 Feb 13;273(7):4135-42. doi: 10.1074/jbc.273.7.4135, PMID 9461608.
Kashani K, Cheungpasitporn W, Ronco C. Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption. Clin Chem Lab Med. 2017 jan 11;55(8):1074-89. doi: 10.1515/cclm-2016-0973, PMID 28076311.
Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Ren Physiol. 2004 Mar;286(3):F552-63. doi: 10.1152/ajprenal.00285.2002, PMID 14600030.
Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008 Apr;73(7):863-9. doi: 10.1038/sj.ki.5002715, PMID 18059454.
Spencer K. Analytical reviews in clinical biochemistry: the estimation of creatinine. Ann Clin Biochem. 1986;23(1):1-25. doi: 10.1177/000456328602300101, PMID 3532908.
Bihorac A, Yavas S, Subbiah S, Hobson CE, Schold JD, Gabrielli A et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg. 2009 May 1;249(5):851-8. doi: 10.1097/SLA.0b013e3181a40a0b, PMID 19387314.
Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2008 Dec;1(3):200-8. doi: 10.1111/j.1752-8062.2008.00053.x, PMID 19212447.
Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury Jul 1. Kidney Int. 2002;62(1):237-44. doi: 10.1046/j.1523-1755.2002.00433.x, PMID 12081583.
Parikh CR, Coca SG, Thiessen-Philbrook H, Shlipak MG, Koyner JL, Wang Z et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol. 2011 Sep 1;22(9):1748-57. doi: 10.1681/ASN.2010121302, PMID 21836143.
Han WK, Wagener G, Zhu Y, Wang S, Lee HT. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol. 2009 May 1;4(5):873-82. doi: 10.2215/CJN.04810908, PMID 19406962.
Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL et al. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci. 2008 Jan 1;101(1):159-70. doi: 10.1093/toxsci/kfm260, PMID 17934191.
Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S. Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail. 2009 Nov 1;31(10):910-9. doi: 10.3109/08860220903216113, PMID 20030526.
Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H et al. Urinary N-acetyl-β-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol. 2007 Mar 1;18(3):904-12. doi: 10.1681/ASN.2006030221, PMID 17267747.